Matterworks
Matterworks turns complex omics measurements into usable biological insights to speed research and development in life sciences. It does this via an AI-driven SaaS platform—including its Large Spectral Model (LSM) and Pyxis product—that ingests mass spectrometry and other metabolomics data and applies machine learning to standardize, interpret, and simulate metabolic environments. The platform emphasizes automation, cloud delivery, and scalability to make unstructured spectral and omics data broadly accessible to biotech teams. Typical users are biotechnology researchers and biomanufacturing groups seeking quantitative, real-time insights for experimental design and process optimization. Matterworks operates at the intersection of AI, metabolomics, and bioinformatics in a market focused on accelerating therapeutic R&D and manufacturing.
Matterworks
Matterworks turns complex omics measurements into usable biological insights to speed research and development in life sciences. It does this via an AI-driven SaaS platform—including its Large Spectral Model (LSM) and Pyxis product—that ingests mass spectrometry and other metabolomics data and applies machine learning to standardize, interpret, and simulate metabolic environments. The platform emphasizes automation, cloud delivery, and scalability to make unstructured spectral and omics data broadly accessible to biotech teams. Typical users are biotechnology researchers and biomanufacturing groups seeking quantitative, real-time insights for experimental design and process optimization. Matterworks operates at the intersection of AI, metabolomics, and bioinformatics in a market focused on accelerating therapeutic R&D and manufacturing.
